Browsing Tag
Olopatadine Hydrochloride
3 posts
Dr. Reddy’s (NSE: DRREDDY) signals dual-track U.S. growth strategy with abatacept biosimilar BLA acceptance and OTC eye-care expansion
Discover how Dr. Reddy’s FDA-accepted abatacept biosimilar and OTC eye-care launch are reshaping its U.S. growth and investor outlook.
Glenmark Pharmaceuticals expands U.S. OTC market presence with Olopatadine Eye Drops
Glenmark secures FDA approval for its OTC Olopatadine Hydrochloride eye drops, expanding its U.S. presence in the $50.7M allergy relief market.
Glenmark Therapeutics takes on Pataday with new OTC eye solution—what you need to know
Glenmark Therapeutics Inc., USA, has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), marking a significant development in…